Publication:
Henoch-Schönlein Nephritis: A Nationwide Study

dc.authorscopusid7004508967
dc.authorscopusid7003365098
dc.authorscopusid7103280649
dc.authorscopusid7005272824
dc.authorscopusid6602708667
dc.authorscopusid8580997300
dc.authorscopusid6603035705
dc.contributor.authorSöylemezoǧlu, O.
dc.contributor.authorÖzkaya, O.
dc.contributor.authorOzen, S.
dc.contributor.authorBakkaloĝlu, A.
dc.contributor.authorDüşünsel, R.
dc.contributor.authorPeru, H.
dc.contributor.authorCetinyurek-Yavuz, A.
dc.date.accessioned2020-06-21T15:08:41Z
dc.date.available2020-06-21T15:08:41Z
dc.date.issued2009
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Söylemezoǧlu] Oǧuz, Department of Pediatric Nephrology, Gazi Üniversitesi, Ankara, Ankara, Turkey; [Özkaya] Ozan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ozen] Seza, Department of Pediatric Nephrology, Hacettepe Üniversitesi, Ankara, Turkey; [Bakkaloĝlu] Ayşin S., Department of Pediatric Nephrology, Hacettepe Üniversitesi, Ankara, Turkey; [Düşünsel] Ruhan, Department of Pediatric Nephrology, Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Peru] Harun, Department of Pediatric Nephrology, Selçuk Üniversitesi, Selçuklu, Konya, Turkey; [Cetinyurek-Yavuz] Aysun, Department of Statistics and Computer Sciences, Başkent Üniversitesi, Ankara, Turkey; [Yildiz] Nurdan, Goztepe Teaching and Research Hospital, İstanbul Tıp Fakültesi, Istanbul, Turkey; [Dönmez] Osman, Department of Pediatric Nephrology, Bursa Uludağ Üniversitesi, Bursa, Bursa, Turkey; [Buyan] Necla, Department of Pediatric Nephrology, Gazi Üniversitesi, Ankara, Ankara, Turkey; [Mir] Sevgi, Department of Pediatric Nephrology, Ege Üniversitesi, Izmir, Turkey; [Arısoy] Nil, Department of Pediatric Rheumatology, İstanbul Tıp Fakültesi, Istanbul, Turkey; [Gür-Güven] Ayfer, Department of Pediatric Nephrology, Akdeniz Üniversitesi, Antalya, Turkey; [Alpay] Harika, Department of Pediatric Nephrology, Marmara Üniversitesi, Istanbul, Turkey; [Ekím] Mesíha, Department of Pediatric Nephrology, Ankara Üniversitesi, Ankara, Turkey; [Aksu] Nejat, Department of Pediatrics, Izmir Tepecik Training and Research Hospital, Izmir, Turkey; [Soylu] Alper, Department of Pediatric Nephrology, Dokuz Eylül Üniversitesi, Izmir, Turkey; [Gök] Faysal, Department of Pediatric Nephrology, Gülhane Eğitim ve Araştırma Hastanesi, Ankara, Turkey; [Poyrazoǧlu] Hakan Muammer, Department of Pediatric Nephrology, Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Sönmez] Ferah, Department of Pediatric Nephrology, Aydin Adnan Menderes University, Aydin, Efeler, Turkeyen_US
dc.description.abstractBackground/Aim: The aim of this retrospective study was to evaluate the presentation, clinical and pathological manifestations and outcome of the Henoch-Schönlein purpura (HSP) nephritis in children. Methods: Clinical and laboratory data of 443 children with HSP nephritis aged between 3 and 16 years from 16 pediatric nephrology reference centers were analyzed retrospectively. The biopsy findings were graded according to the classification developed by the International Study of Kidney Disease in Children (ISKDC). Results: Renal biopsy was performed in 179 of the patients with HSP nephritis. The most common presenting clinical finding in patients who were biopsied was nephrotic range proteinuria (25%) which was followed by nephritic-nephrotic syndrome (23.5%). The biopsy findings according to the ISKDC were as follows: class I: 8.3%; II: 44.1%; III: 36.3%; IV: 6.7%; V: 3.3%; VI: 1.1%. All of the patients who developed end-stage renal disease had nephritic-nephrotic syndrome at presentation. Of 443 patients, 87.2% had a favorable outcome and 12.8% had an unfavorable outcome. The overall percentage of children who developed end-stage renal disease at follow-up was 1.1%. Logistic regression analysis did not show any association of initial symptoms and histology with outcome. Conclusion: In the presented cohort, the presence of crescents in the first biopsy or presenting clinical findings did not seem to predict the outcome of HSP nephritis in children. We conclude that children with HSP nephritis even with isolated microscopic hematuria and/or mild proteinuria should be followed closely. © 2009 S. Karger AG, Basel.en_US
dc.identifier.doi10.1159/000218109
dc.identifier.endpagec204en_US
dc.identifier.issn1660-2110
dc.identifier.issue3en_US
dc.identifier.pmid19439991
dc.identifier.scopus2-s2.0-65549167509
dc.identifier.startpagec199en_US
dc.identifier.urihttps://doi.org/10.1159/000218109
dc.identifier.volume112en_US
dc.identifier.wosWOS:000266882400012
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofNephron - Clinical Practiceen_US
dc.relation.journalNephron Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.subjectHenoch-Schönlein Purpuraen_US
dc.subjectNephritisen_US
dc.subjectOutcomeen_US
dc.subjectTreatmenten_US
dc.titleHenoch-Schönlein Nephritis: A Nationwide Studyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files